These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2892767

  • 1. Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in rats.
    Lefevre-Borg F, Lorrain J, Lechaire J, Thiry C, Lhoste F, Hicks PE, Cavero I.
    Fundam Clin Pharmacol; 1987; 1(3):179-200. PubMed ID: 2892767
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I, Lefevre-Borg F, Lhoste F, Sabatier C, Richer C, Giudicelli JF.
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats.
    Cavero I, Thiry C, Pratz J, Lawson K.
    Clin Exp Hypertens A; 1987 Mar; 9(5-6):931-52. PubMed ID: 2887315
    [Abstract] [Full Text] [Related]

  • 4. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
    Le Monnier de Gouville AC, Lawson K, Thiry C, Cavero I.
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I, Lorrain J, Di Paola ED, Lhoste F, Payen B, Dennis T, Scatton B.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats.
    Sengupta S, Lokhandwala MF.
    J Auton Pharmacol; 1985 Dec; 5(4):289-94. PubMed ID: 2869041
    [Abstract] [Full Text] [Related]

  • 7. Identification of dopamine receptor subtypes in the hypotensive action of SK&F 85174 in anesthetized rats.
    Sowinski BA, Lokhandwala MF.
    J Auton Pharmacol; 1987 Jun; 7(2):105-9. PubMed ID: 2888767
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G, Demenge P.
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):548-55. PubMed ID: 1724532
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of quinpirole on autonomic nervous control of heart rate in rats.
    Roquebert J, Moran A, Sauvage MF, Demichel P.
    Fundam Clin Pharmacol; 1992 Oct; 6(2):67-73. PubMed ID: 1351472
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular effects of bromocriptine in rats: role of peripheral adrenergic and dopaminergic receptors.
    Roquebert J, Alaoui K, Morán Benito A.
    J Auton Pharmacol; 1990 Apr; 10(2):85-96. PubMed ID: 2161850
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.
    Le Monnier de Gouville AC, Mondot S, Lippton H, Hyman A, Cavero I.
    J Pharmacol Exp Ther; 1990 Jan; 252(1):300-11. PubMed ID: 2405151
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA1 and DA2 receptor agonists and antagonists.
    Sabouni MH, Alkadhi KA, Lokhandwala MF.
    J Pharmacol Exp Ther; 1986 Jan; 236(1):65-70. PubMed ID: 2867216
    [Abstract] [Full Text] [Related]

  • 16. B-HT 958 lowers blood pressure and heart rate in the rat through stimulation of dopamine receptors.
    Brown MJ, Harland D.
    Br J Pharmacol; 1986 Feb; 87(2):361-70. PubMed ID: 3006858
    [Abstract] [Full Text] [Related]

  • 17. Hypotensive and regional haemodynamic effects of fenoldopam and quinpirole in the anaesthetized rat.
    Van der Niepen P, Dupont AG, Finne E, Six RO.
    J Hypertens Suppl; 1988 Dec; 6(4):S687-9. PubMed ID: 2907350
    [Abstract] [Full Text] [Related]

  • 18. Effect of quinpirole, a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs.
    Damase-Michel C, Montastruc JL, Gharib C, Geelen G, De Saint-Blanquat G, Tran MA.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):770-7. PubMed ID: 1968975
    [Abstract] [Full Text] [Related]

  • 19. Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
    Hahn RA, MacDonald BR.
    J Pharmacol Exp Ther; 1984 Sep; 230(3):558-68. PubMed ID: 6470973
    [Abstract] [Full Text] [Related]

  • 20. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF, Jin HK, Paul R, Nagahama S.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.